{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:23:36Z","timestamp":1781047416160,"version":"3.54.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hyperammonemia is critical to the development of hepatic encephalopathy (HE) and is associated with mortality in end-stage liver disease. This study investigated the clinical value of ammonia variation in hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 276 patients with HBV-ACLF were retrospectively recruited. Patients' ammonia levels were serially documented. Baseline ammonia, Peak ammonia (highest level), and Trough ammonia (lowest level) were particularly corrected to the upper limit of normal (AMM-ULN). The primary endpoint was 28-day mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The 28-day, 3-month, and 12-month mortality rates were 19.2, 25.7, and 28.2%, respectively. A total of 51 (18.4%) patients had overt HE (grade 2\/3\/4). Peak AMM-ULN was significantly higher in patients with overt HE and non-survivors compared with their counterparts (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). Following adjustment for significant confounders, high Peak AMM-ULN was an independent predictor of overt HE (hazard ratio, 1.031, <jats:italic>P<\/jats:italic> &amp;lt; 0.001) and 28-day mortality (hazard ratio, 1.026, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). The cut-off of Peak AMM-ULN was 1.8, determined by using the X-tile. Patients with Peak AMM-ULN appearing on days 1\u20133 after admission had a higher proportion of overt HE and mortality compared to other groups. Patients with decreased ammonia levels within 7 days had better clinical outcomes than those with increased ammonia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Serum Peak ammonia was independently associated with overt HE and mortality in HBV-ACLF patients. Serial serum ammonia may have prognostic value.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2023.1282106","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T04:44:40Z","timestamp":1701665080000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum ammonia variation predicts mortality in patients with hepatitis B virus-related acute-on-chronic liver failure"],"prefix":"10.3389","volume":"14","author":[{"given":"Yi-Jing","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Cong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Qian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Qing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.14309\/ajg.0000000000000384","article-title":"Variability and lability of ammonia levels in healthy volunteers and patients with cirrhosis: implications for trial design and clinical practice","volume":"115","author":"Bajaj","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/hep.21838","article-title":"Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure","volume":"46","author":"Bernal","year":"2007","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/gut.2004.061754","article-title":"Predictive value of arterial ammonia for complications and outcome in acute liver failure","volume":"55","author":"Bhatia","year":"2006","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.12998\/wjcc.v9.i3.552","article-title":"Role of ammonia in predicting the outcome of patients with acute-on-chronic liver failure","volume":"9","author":"Chiriac","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"B5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","article-title":"Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)","volume":"60","author":"Cordoba","year":"2014","journal-title":"J. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.clinthera.2022.01.008","article-title":"Serum ammonia in cirrhosis: clinical impact of hyperammonemia, utility of testing, and national testing trends","volume":"44","author":"Deutsch-Link","year":"2022","journal-title":"Clin. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/clinchem\/30.6.906","article-title":"Influences of specimen processing and storage conditions on results for plasma ammonia","volume":"30","author":"Howanitz","year":"1984","journal-title":"Clin. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"16970","DOI":"10.1038\/s41598-020-73603-1","article-title":"Serum ammonia is a strong prognostic factor for patients with acute-on-chronic liver failure","volume":"10","author":"Hu","year":"2020","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jhep.2015.11.019","article-title":"Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension","volume":"64","author":"Jalan","year":"2016","journal-title":"J. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/liv.12365","article-title":"Hyperammonaemia induces hepatic injury with alteration of gene expression profiles","volume":"34","author":"Jia","year":"2014","journal-title":"Liver Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.29107","article-title":"Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis","volume":"65","author":"Kumar","year":"2017","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/hep.30692","article-title":"Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis","volume":"70","author":"Nardelli","year":"2019","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1016\/j.cgh.2020.10.019","article-title":"Efficacy and safety of ornithine phenylacetate for treating overt hepatic encephalopathy in a randomized trial","volume":"19","author":"Rahimi","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jhep.2014.09.005","article-title":"Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure","volume":"62","author":"Romero-Gomez","year":"2015","journal-title":"J. Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1016\/j.cgh.2021.01.046","article-title":"Erroneous ammonia measurement is not synonymous with a lack of efficacy of ammonia-lowering therapies in hepatic encephalopathy","volume":"19","author":"Rose","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol. Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/lt.24443","article-title":"Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute-on-chronic liver failure patients","volume":"22","author":"Sawhney","year":"2016","journal-title":"Liver Transpl."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1080\/00365521.2017.1374449","article-title":"Predictors of infection in viral-hepatitis related acute liver failure","volume":"52","author":"Shalimar","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/jgh3.12314","article-title":"Persistent or incident hyperammonemia is associated with poor outcomes in acute decompensation and acute-on-chronic liver failure","volume":"4","author":"Shalimar","year":"2020","journal-title":"JGH Open"},{"key":"B21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/hep.30534","article-title":"Prognostic role of ammonia in patients with cirrhosis","volume":"70","author":"Shalimar","year":"2019","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/jgh.13666","article-title":"Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy","volume":"32","author":"Sharma","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/hep.22474","article-title":"Ammonia impairs neutrophil phagocytic function in liver disease","volume":"48","author":"Shawcross","year":"2008","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.jhep.2022.07.014","article-title":"Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis","volume":"77","author":"Tranah","year":"2022","journal-title":"J. Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/s12072-021-10221-7","article-title":"Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure","volume":"15","author":"Verma","year":"2021","journal-title":"Hepatol. Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the american association for the study of liver diseases and the european association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e23553","DOI":"10.1002\/jcla.23553","article-title":"Ammonia predicts poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure","volume":"34","author":"Zhang","year":"2020","journal-title":"J. Clin. Lab. Anal."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1282106\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T04:44:46Z","timestamp":1701665086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1282106\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":27,"alternative-id":["10.3389\/fmicb.2023.1282106"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1282106","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,4]]},"article-number":"1282106"}}